SCHEDULES
SCHEDULE 2 Controlled Drugs
Part III Class C Drugs
1
The following substances, namely:—
F1a
F2Alprazolam.
F3Aminorex
Benzphetamine.
F2Bromazepam.
F3Brotizolam
F4Buprenorphine
F2Camazepam.
F19Cannabinol
F19Cannabinol derivatives
F19Cannabis and cannabis resin
F5Cathine.
F5Cathinone.
F2Chlordiazepoxide.
Chlorphentermine.
F2Clobazam.
F2Clorazepic acid.
F2Clonazepam.
F2Clotiazepam.
F2Cloxazolam.
F2Delorazepam.
F6Dextropropoxyphene.
F2Diazepam.
F7Diethylpropion.
F2Estazolam.
F2Ethchlorvynol.
F2Ethinamate.
F2Ethyl loflazepate.
F5Fencamfamin.
F5Fenethylline.
F5Fenproporex.
F2Fludiazepam.
F2Flunitrazepam.
F2Flurazepam.
F2Halazepam.
F2Haloxazolam.
F154-Hydroxy-n-butyric acid
F21Ketamine
F2Ketazolam.
F2Loprazolam.
F2Lorazepam.
F2Lormetazepam.
F2Mazindol.
F2Medazepam.
F5Mefenorex.
F8. . .
Mephentermine.
F2Meprobamate.
F3Mesocarb
F9. . .
F2Methyprylone.
F10Midazolam.
F2Nimetazepam.
F2Nitrazepam.
F2Nordazepam.
F2Oxazepam.
F2Oxazolam.
F11Pemoline.
F8. . .
Phendimetrazine.
F2Phentermine.
F2Pinazepam.
F8. . .
Pipradrol.
F2Prazepam.
F8. . .
F12. . .
F5Pyrovalerone.
F2Temazepam.
F2Tetrazepam.
F2Triazolam.
F5N-Ethylamphetamine.
F16Zolpidem
F13b
F174-Androstene-3, 17-dione
F175-Androstene-3, 17-diol
Atamestane.
Bolandiol.
Bolasterone.
Bolazine.
Boldenone.
Bolenol.
Bolmantalate.
Calusterone.
4-Chloromethandienone.
Clostebol.
Drostanolone.
Enestebol.
Epitiostanol.
Ethyloestrenol.
Fluoxymesterone.
Formebolone.
Furazabol.
Mebolazine.
Mepitiostane.
Mesabolone.
Mestanolone.
Mesterolone.
Methandienone.
Methandriol.
Methenolone.
Methyltestosterone.
Metribolone.
Mibolerone.
Nandrolone.
F1819-Nor-4-Androstene-3, 17-dione
F1819-Nor-5-Androstene-3, 17-diol
Norboletone.
Norclostebol.
Norethandrolone.
Ovandrotone.
Oxabolone.
Oxandrolone.
Oxymesterone.
Oxymetholone.
Prasterone.
Propetandrol.
Quinbolone.
Roxibolone.
Silandrone.
Stanolone.
Stanozolol.
Stenbolone.
Testosterone.
Thiomesterone.
Trenbolone.
c
any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,
i
by further substitution at position 17 by a methyl or ethyl group;
ii
by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
iii
by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;
iv
by fusion of ring A with a heterocyclic system;
d
any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above F20or of cannabinol or a cannabinol derivative ;
e
Chorionic Gonadotrophin (HCG).
Clenbuterol.
Non-human chorionic gonadotrophin.
Somatotropin.
Somatrem.
Somatropin.
2
Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule F14not being phenylpropanolamine.
3
Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.
4
Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.